MSB ASX · Health Care

Mesoblast Ltd

Announcements, last 12 months: 114
Price sensitive, last 12 months: 22
Followed on InvestorPA: Moderate (Among the 13% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
5 Nov 2026, 9:58 AM	Use of Ryoncil Highlighted in Key Opinion Leader Webinar
2 Nov 2026, 10:01 AM	Final Director's Interest Notice
2 Nov 2026, 9:59 AM	Mesoblast Board Changes
29 Oct 2026, 9:54 AM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
27 Oct 2026, 6:52 PM	Becoming a substantial holder
26 Oct 2026, 7:24 PM	Ceasing to be a substantial holder
22 Oct 2026, 7:20 PM	Becoming a substantial holder
16 Oct 2026, 10:15 AM	MSB Reports Increased Revenue and Improved Operating Spend Price sensitive	AI summary
14 Oct 2026, 5:10 PM	Notification of cessation of securities - MSB
14 Oct 2026, 5:07 PM	Notification regarding unquoted securities - MSB

Sign in to see all MSB announcements.

Guidance history

27 Aug 2026	Total revenue of US$120.3 million for FY2026
27 Aug 2026	Net revenue US$115M in FY2026, first full year post launch
17 Aug 2026	Top-line results expected in mid-CY2027

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow MSB to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.